Idiopathic Pulmonary Fibrosis (IPF) is a chronic, life-threatening condition where lung tissue becomes scarred over a period of time, leading to a patient’s inability to transfer oxygen into their bloodstream. Boehringer Ingelheim is a leader in respiratory care with a focus on IPF and improving the quality of life of those who suffer from this very rare disease. OFEV is a leading pharmaceutical treatment for IPF, and I helped build its digital direct-to-consumer brand.
Creative Director: Nathan Gomez
Art Director: Nathan Gamson
Copywriter: Lori Hodgen
UX Lead: Anup Sheth
Client: Boehringer Ingelheim
Agency: Wunderman Thompson
If a pharmaceutical advertisement (whether a website, magazine ad, digital banner, or video) makes any medical claim, it is required to dedicate space to “Important Safety Information.” This block of information, the ISI, will include: basic information, safety warnings, indications, contraindications, potential side effects, and FDA contact information. On a website, the ISI must be present at all times on every possible device, so we designed a responsive layout around this section.
